Unequally Indebted: Debt by Education, Race, and Ethnicity and the, Accumulation of Inequality in Emerging Adulthood.

Emerging adults in the U.S. face significant economic uncertainty during the early life course.

The Accumulation of Disadvantage: Criminal Justice Contact, Credit, and Debt in the Transition to Adulthood.

Social exclusion of those with criminal justice experience increasingly includes a financial component, but the structure of disadvantage in credit and debt remains unclear. We develop a model of financial disadvantage in debt-holding during the transition to adulthood among justice-involved groups. We study cumulative criminal justice contact and debt holding by age thirty using the NLSY97.

Evaluating PROMIS Physical Function Measures in Older Adults at Risk for Alzheimer's Disease.

Activities of daily living can be affected by cognitive decline. Self-report measurement of functioning is attractive due to ease of data collection, low cost, and accessibility via technology-assisted means, and for understanding patient perspective. A concern is with reliability of such measurement as cognitive decline occurs.

Susceptibility to toxoplasmic retinochoroiditis is associated with HLA alleles reported to be implicated with rapid progression to AIDS.

Background/aims: The frequency of HLA markers associated with rapid progression to AIDS was evaluated in Brazilian patients with AIDS exhibiting or not toxoplasmic retinochoroiditis (TRC).

Methods: 98 AIDS patients (25 with TRC, 43 with anti-T. gondii antibodies but without TCR, and 30 without anti-T.

Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.

Purpose: We evaluated the efficacy of gemcitabine versus gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer (NSCLC) and a performance status (PS) of 2 and assessed if tumoral RRM1 and ERCC1 protein levels are predictive of response to therapy.

Patients And Methods: A randomized phase III trial was conducted in community-based oncology practices. Tumor specimens were collected a priori and shipped to a single laboratory for blinded determination of in situ RRM1 and ERCC1 protein expression levels by an automated quantitative immunofluorescent-based technology.